Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · IEX Real-Time Price · USD
114.97
+1.51 (1.33%)
At close: Jul 19, 2024, 4:00 PM
114.91
-0.06 (-0.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Blueprint Medicines Employees
Blueprint Medicines had 655 employees as of December 31, 2023. The number of employees increased by 14 or 2.18% compared to the previous year.
Employees
655
Change (1Y)
14
Growth (1Y)
2.18%
Revenue / Employee
$430,853
Profits / Employee
-$440,131
Market Cap
7.20B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 655 | 14 | 2.18% |
Dec 31, 2022 | 641 | 146 | 29.49% |
Dec 31, 2021 | 495 | 66 | 15.38% |
Dec 31, 2020 | 429 | 46 | 12.01% |
Dec 31, 2019 | 383 | 166 | 76.50% |
Dec 31, 2018 | 217 | 68 | 45.64% |
Dec 31, 2017 | 149 | 43 | 40.57% |
Dec 31, 2016 | 106 | 25 | 30.86% |
Dec 31, 2015 | 81 | 20 | 32.79% |
Dec 31, 2014 | 61 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
The Ensign Group | 35,300 |
Penumbra | 4,200 |
Jazz Pharmaceuticals | 2,800 |
Tempus AI | 1,952 |
Repligen | 1,783 |
Ionis Pharmaceuticals | 927 |
Ascendis Pharma | 879 |
Revolution Medicines | 378 |
BPMC News
- 2 days ago - Blueprint Medicines Corporation Investors Are Informed By The Schall Law Firm Of Ongoing Investigations Into Possible Securities Law Breaches - Accesswire
- 3 days ago - The Schall Law Firm Is Currently Investigating Potential Violations Of Securities Laws For Investors Of Blueprint Medicines Corporation - Accesswire
- 3 days ago - Blueprint Medicines to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 - PRNewsWire
- 4 days ago - The Schall Law Firm Is Presently Probing Possible Breaches Of Securities Laws For Blueprint Medicines Corporation Investors - Accesswire
- 8 days ago - The Schall Law Firm Is At Present Conducting An Inquiry Into Possible Breaches Of Securities Laws For Blueprint Medicines Corporation Investors - Accesswire
- 9 days ago - The Schall Law Firm Is Currently Investigating Potential Violations Of Securities Laws For Investors In Blueprint Medicines Corporation - Accesswire
- 10 days ago - Currently The Schall Law Firm Is Investigating Potential Violations Of Securities Laws For Shareholders Of Blueprint Medicines Corporation - Accesswire
- 11 days ago - At Present The Schall Law Firm Is Probing Possible Breaches Of Securities Laws For Shareholders Of Blueprint Medicines Corporation - Accesswire